medsynapse-hcp
Introduction: Elevated intraocular pressure (IOP) remains the most important modifiable risk factor in the progression of open-angle glaucoma (OAG) and ocular hypertension (OHT) (1). Despite multiple therapeutic options, limitations persist with existing agents such as β-blockers (e.g., timolol), including systemic side effects, variable efficacy a
Netarsudil 0.02% in Elevated Intraocular Pressure: Insights from the Phase 3 ROCKET-1 and ROCKET-2 Trials

Netarsudil 0.02% in Elevated Intraocular Pressure: Insights from the Phase 3 ROCKET-1 and ROCKET-2 Trials

5 Reached

Similar Content

Safe Ramadan Practices during COVID-19 - WHO Guidance
Safe Ramadan Practices during COVID-19 - WHO Guidance
6562 Reached8 Comments3 Likes
<p>How Physicians Should Manage Stress?</p>

How Physicians Should Manage Stress?

35340 Reached151 Comments202 Likes
Managing Meconium Aspiration Syndrome in Infants
Managing Meconium Aspiration Syndrome in Infants
9817 Reached7 Comments8 Likes
Infant with Congenital Diaphragmatic Hernia (CDH)
Infant with Congenital Diaphragmatic Hernia (CDH)
6992 Reached14 Comments8 Likes
Woman presented with Fever of Unknown Origin
Woman presented with Fever of Unknown Origin
7743 Reached93 Comments19 Likes